Physician profile
Dessislava V Boneva
NPI 1558486498
$12,598.26
in general payments reported to CMS, 2019-2025
7 companies · $268 in 2025
The $268 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $166 · 2021: $750 · 2022: $280 · 2023: $10K · 2024: $494 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $1,602 · Food and Beverage: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $1,602.07 |
| Food and Beverage | $1,094.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,300.16 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $1,398.73 | 2021-2025 | Ribfix Titan, Advantagerib |
| Organogenesis INC. | $205.70 | 2019 | |
| Atricure, INC. | $198.18 | 2021-2024 | |
| Davol INC. | $174.22 | 2024 | Phasix Mesh |
| Sanara Medtech INC. | $165.84 | 2020 | |
| Silk Road Medical, INC. | $155.43 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dessislava Boneva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.